GENE ONLINE|News &
Opinion
Blog

Region
ITALY Pavilion Offers Immense Value at BIO ASIA-TAIWAN 2020 – ONLINE
2020-10-13Partner
Asia-Pacific Healthcare
HoldingTOP Delivers a Mobilized Long-Term Care Service, a First in Taiwan
2020-10-13Partner
Trials & Approvals Rituximab
Innovent Biologics Bags Chinese Approval for Fourth Monoclonal Antibody
2020-10-12
AATD
Takeda Collaborates with Arrowhead to Overcome Inherited Disorder via RNAi Therapy
2020-10-10
Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System
2020-10-08
CAR-T Cell
China-Based Immunotherapy Company Receives FDA’s Orphan Drug Designation for Advanced Gastric Cancer Treatment
2020-10-07
DNA Amplification
Tokyo-Based Genomics Company Launches World’s First Cell-Free DNA Amplification Process
2020-10-04
Startups Anti-PD-L1 Therapy
Pfizer Strengthens Immuno-Oncology Portfolio with $200 Million Investment in Chinese Startup
2020-10-03
Trials & Approvals Glioblastoma
China Approves Avastin’s New Indication
2020-09-25
Asia-Pacific CAR T-cell Therapy
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
Eisai
Eisai Enters Vietnam With a Subsidiary
2020-09-18
R&D Cancer
3SBio Partnering with Samsung Bioepis Co-developing Bevacizumab Biosimilar for NSCLC
2020-09-16
Trials & Approvals Bone Health
Korean Ginseng Gets Approved for a Functional Ingredient for Bone Health
2020-09-13
Cannabis
Relaxation of CBD Restriction Sparks Controversy
2020-09-12
COVID-19 Vaccine
Cooperation of Two Chinese Pharma Launched Massive Clinical Trials Abroad
2020-09-08
1 … 29 30 31 32 33 … 42
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top